Medical Director, MedStar Health Cancer Network
Oncology
Dr. Stephen J. Noga, MD
|
|
Give Review
Stephen J. Noga, MD works in the field of Oncology. He went to medical school at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical college. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Stephen J. Noga, MD is also a published doctor. He has 76 publication published. The most recent publication is: Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing''s sarcoma. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.
- A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myeloma.
- Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.
- Retreatment with bortezomib alone or in combination for patients with multiple myeloma following an initial response to bortezomib.
- Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) conTract research pr...
- Low incidence of neutropenic events in patients with Lymphoma receiving first-cycle pegfilgrastim with chemotherapy: results from a prospective community-based study.
- Neutropenic events in community practices reduced by first and subsequent cycle pegfilgrastim use.
- Long-term follow-up of T cell-depleted allogeneic Bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells.
- A closed and single-use System for monocyte enrichment: potential for dendritic cell generation for clinical applications.
- NCCN: Multiple myeloma.
- Interferon-gamma potentiates the antitumor effect of cyclosporine-induced autoimmunity.
- Bone marrow micrometastases in chemotherapy-responsive advanced breast Cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide.
- Sensitivity of monocyte subpopulations to cyclosporine. Arachidonate metabolism and in vitro antigen presentation.
- Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): testosterone regulates AR expression.
- Ex vivo cultured megakaryocytes express functional glycoprotein IIb-IIIa receptors and are capable of adenovirus-mediated transgene expression.
- Cell cycle-specific behavior of erythropoietin.
- Graft engineering: the evolution of hematopoietic transplantation.
- Thymic regulation of hematopoiesis. III: Isolation of helper and suppressor populations using counterflow centrifugal elutriation.
- Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human Bone marrow.
- Large scale separation of human Bone marrow by counterflow centrifugation elutriation.
- Using mislabeled medium: who is at fault?
- Rapid separation of whole human Bone marrow aspirates by counterflow centrifugation elutriation.
- Implementation of a semiclosed large scale counterflow centrifugal elutriation System.
- Absence of breast Cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimul...
- Concentration of large volume peripheral blood stem cell products using the COBE 2991.
- Comparison of progenitor cell concentration techniques: continuous flow separation versus density-gradient isolation.
- Characterization of YB2/0 cell line by counterflow centrifugation elutriation.
- Large-volume leukapheresis using regional citrate antiCoagulation to collect peripheral blood progenitor cells.
- The clinical use of elutriation and positive stem cell selection columns to engineer the lymphocyte and stem cell composition of the allograft.
- Effectiveness of rotor off fraction in allogeneic murine Bone marrow transplantation with complete disparity of major histocompatibility.
- Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34+ cells.
- Isolation of cell cycle fractions by counterflow centrifugal elutriation.
- Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing''s sarcoma.
- Immunological heterogeneity of human monocyte subsets prepared by counterflow centrifugation elutriation.
- Engineering hematopoietic grafts using elutriation and positive cell selection to reduce GVHD.
- 4-Hydroperoxycyclophosphamide treatment of stored Bone marrow grafts.
- Graft engineering.
- Cyclosporine A enhances the natural suppressor monocyte precursor population in the rat.
- Using point-of-care CD34 enumeration to optimize PBSC collection conditions.
- Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-...
- Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograft products from multiple myeloma patients.
- Lymphocyte depletion in bone marrow transplantation: will modulation of graft-versus-host Disease prove to be superior to prevention?
- Similar breast Cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or af...
- Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma.
- Autologous graft-versus-host disease induction in advanced breast Cancer: role of peripheral blood progenitor cells.
- Highly purified CD34-positive cells reconstitute hematopoiesis.
- Recovery of the simian immunodeficiency virus (SIV) and depression of colony formation in in vitro infected progenitor cell-enriched rhesus Bone marrow (BM).
- Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous...
- CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host Disease prophylaxis...
- Engraftment following in utero Bone marrow transplantation for globoid cell leukodystrophy.
- The combined use of elutriation and CD8/magnetic bead separation to engineer the Bone marrow allograft.
- Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple ...
- Autologous graft-versus-host Disease: a novel approach for antitumor immunotherapy.
- Autologous graft-versus-host Disease: a new frontier in immunotherapy.
- Using elutriation to engineer Bone marrow allografts.
- Long-term results of blood and marrow transplantation for Hodgkin's Lymphoma.
- Chemotherapy does not nullify the ability of donor lymphocyte infusions to mediate graft-versus-host reactions.
- Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study.
- Regeneration of genetically restricted immune functions after human bone marrow transplantation: influence of four different strategies for graft-v-host Disease prophy...
- High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant Diseases.
- Elutriation of Bone marrow delineates two distinct natural suppressor cell populations.
- Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival.
- Characterization of the natural suppressor cell population in adult rat Bone marrow.
- Separation of rat Bone marrow cells by counterflow centrifugal elutriation: a model for studying the effects of lymphocyte depletion.
- CD34+ stem cell augmentation of allogeneic, elutriated Marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity.
- Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial.
- Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's Lymphoma.
- CD34 selection using three immunoselection devices: comparison of T-cell depleted allografts.
- CD34 augmentation improves allogeneic T cell-depleted Bone marrow engraftment.
- Lymphocyte depletion of donor Bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial.
- Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's ...
- Philadelphia chromosome-negative engraftment after autologous transplantation with granulocyte-macrophage colony-stimulating factor for chronic myeloid Leukemia.
- Allogeneic bone marrow transplantation in patients with sensitive low-grade Lymphoma or mantle cell Lymphoma.
- A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk Acute myeloid leukemi...
- Palifermin for oral mucositis after intensive therapy for hematologic Cancers.
Schools
Johns Hopkins University School Of Medicine
Johns Hopkins University
Procedures Preformed
- Bone Marrow Aspiration
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Acute Monocytic Leukemia
- Acute Myeloid Leukemia
- Adrenal Gland Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
Johns Hopkins University School of Medicine
Hospital
-
MedStar Harbor Hospital -
University of Maryland Medical Center
Drug Facts
| NPI NUMBER | 1023051000 | |
| NPPES Provider LastName | NOGA | |
| NPPES Provider FirstName | STEPHEN | |
| NPPES Provider ZIPCode | 21215 | |
| NPPES Provider State | MD | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 213.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023051000 |
| Last Name Of The Provider | NOGA |
| First Name Of The Provider | STEPHEN |
| View All |
Similar Doctors
|
|
Dr. William P. McGuire III, MD |
|
|
Dr. Michael Kraut, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pallavi P. Kumar, MD
This Doctor is OpenDoctor Recommended.
|